Stock Track | Atai Beckley Soars 10.03% Intraday Following Positive Analyst Ratings and BPL-003 Optimism

Stock Track03-09 21:36

Atai Beckley Inc's stock soared 10.03% during intraday trading on Monday, extending gains from earlier pre-market activity. The significant upward movement reflects heightened investor interest driven by recent analyst evaluations.

The surge follows a series of positive analyst actions, including Needham reiterating its Buy rating on the company. Analysts highlighted the differentiated profile, pricing power, and long-dated intellectual property protection of Atai Beckley's drug candidate BPL-003, which is being developed for treatment-resistant depression.

Additionally, Needham maintained a price target of $14.00 per share for Atai Beckley. The combination of reiterated confidence from analysts and specific optimism around the company's pipeline appears to have fueled the substantial intraday gain, building upon pre-market strength observed earlier in the trading session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1107398277?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-09 21:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1107398277","market":"nz","top_or_hot":-1,"title":"Stock Track | Atai Beckley Soars 10.03% Intraday Following Positive Analyst Ratings and BPL-003 Optimism","media":"Stock Track","content":"<p>Atai Beckley Inc's stock soared 10.03% during intraday trading on Monday, extending gains from earlier pre-market activity. The significant upward movement reflects heightened investor interest driven by recent analyst evaluations.</p><p>The surge follows a series of positive analyst actions, including Needham reiterating its Buy rating on the company. Analysts highlighted the differentiated profile, pricing power, and long-dated intellectual property protection of Atai Beckley's drug candidate BPL-003, which is being developed for treatment-resistant depression.</p><p>Additionally, Needham maintained a price target of $14.00 per share for Atai Beckley. The combination of reiterated confidence from analysts and specific optimism around the company's pipeline appears to have fueled the substantial intraday gain, building upon pre-market strength observed earlier in the trading session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Atai Beckley Soars 10.03% Intraday Following Positive Analyst Ratings and BPL-003 Optimism</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Atai Beckley Soars 10.03% Intraday Following Positive Analyst Ratings and BPL-003 Optimism\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-09 21:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Atai Beckley Inc's stock soared 10.03% during intraday trading on Monday, extending gains from earlier pre-market activity. The significant upward movement reflects heightened investor interest driven by recent analyst evaluations.</p><p>The surge follows a series of positive analyst actions, including Needham reiterating its Buy rating on the company. Analysts highlighted the differentiated profile, pricing power, and long-dated intellectual property protection of Atai Beckley's drug candidate BPL-003, which is being developed for treatment-resistant depression.</p><p>Additionally, Needham maintained a price target of $14.00 per share for Atai Beckley. The combination of reiterated confidence from analysts and specific optimism around the company's pipeline appears to have fueled the substantial intraday gain, building upon pre-market strength observed earlier in the trading session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ATAI","symbol_name":"Atai Beckley Inc","start_time":0,"source_url":"","article_id":"1107398277","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1107398277","pubTimestamp":1773063412,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Atai Beckley Inc's stock soared 10.03% during intraday trading on Monday, extending gains from earlier pre-market activity. The significant upward movement reflects heightened investor interest...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ATAI":"Atai Beckley Inc"},"translate_title":"个股追踪|Atai Beckley盘中飙升10.03%，因分析师正面评级和BPL-003乐观","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ATAI":1},"content_text":"Atai Beckley Inc's stock soared 10.03% during intraday trading on Monday, extending gains from earlier pre-market activity. The significant upward movement reflects heightened investor interest driven by recent analyst evaluations.The surge follows a series of positive analyst actions, including Needham reiterating its Buy rating on the company. Analysts highlighted the differentiated profile, pricing power, and long-dated intellectual property protection of Atai Beckley's drug candidate BPL-003, which is being developed for treatment-resistant depression.Additionally, Needham maintained a price target of $14.00 per share for Atai Beckley. The combination of reiterated confidence from analysts and specific optimism around the company's pipeline appears to have fueled the substantial intraday gain, building upon pre-market strength observed earlier in the trading session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1107398277","isCrawlerRequest":true}